FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation
Authors
Keywords
Phosphorylation, Mouse models, Hippocampus, Alzheimers disease, Apoptosis, Enzyme-linked immunoassays, Memory, Learning and memory
Journal
PLoS One
Volume 8, Issue 11, Pages e78033
Publisher
Public Library of Science (PLoS)
Online
2013-11-05
DOI
10.1371/journal.pone.0078033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation
- (2012) Kailie Luan et al. AGEING RESEARCH REVIEWS
- Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography–tandem mass spectrometry
- (2012) Jinfeng Hou et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Tau Oligomers as Potential Targets for Immunotherapy for Alzheimers Disease and Tauopathies
- (2011) C. A. Lasagna-Reeves et al. Current Alzheimer Research
- Age-dependent Accumulation of Soluble Amyloid β (Aβ) Oligomers Reverses the Neuroprotective Effect of Soluble Amyloid Precursor Protein-α (sAPPα) by Modulating Phosphatidylinositol 3-Kinase (PI3K)/Akt-GSK-3β Pathway in Alzheimer Mouse Model
- (2011) Sebastian Jimenez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Unknown
- (2011) Daniel Paris et al. MOLECULAR MEDICINE
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
- Bapineuzumab
- (2010) Geoffrey A Kerchner et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons
- (2010) Zhaoxu Zhang et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model
- (2009) Yingxin Yu et al. HIPPOCAMPUS
- Role of Amyloid- Glycine 33 in Oligomerization, Toxicity, and Neuronal Plasticity
- (2009) A. Harmeier et al. JOURNAL OF NEUROSCIENCE
- Novel squamosamide derivative (compound FLZ) attenuates Aβ25–35-induced toxicity in SH-SY5Y cells
- (2008) Fang FANG et al. ACTA PHARMACOLOGICA SINICA
- Blocking A 42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between A and Tau Pathology
- (2008) S. Oddo et al. JOURNAL OF NEUROSCIENCE
- Retinoic Acid Attenuates -Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model
- (2008) Y. Ding et al. JOURNAL OF NEUROSCIENCE
- Amyloid Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization
- (2008) I. Klyubin et al. JOURNAL OF NEUROSCIENCE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- β-Secretase as a therapeutic target for Alzheimer’s disease
- (2008) Arun K. Ghosh et al. Neurotherapeutics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now